Hexavalent Vaccine — A Combination Vaccine against Diphtheria, Tetanus, Whooping Cough, Polio, Hib and Hepatitis B

Folkehelseinstituttet

The Norwegian Institute of Public Health shall enter into a contract for the purchase of a combination vaccine for diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (hexavalent vaccine), for the national vaccine programme. The tender contest is carried out on behalf of the Norwegian Institute of Public Health (HOD). Norway has had a hexavalent vaccine programme since 2016. The current contract expires 31.12.2019 and shall be replaced by a new contract subsequent to the tender competition.
The procurement shall be implemented as an open tender contest in accordance with the Public Procurement Regulations' Parts 1 and 3. The procurement shall be implemented electronically via the CTM-KGV portal (Eu-Supply) and the tender notice is published in Doffin and TED.

Frist

Fristen for mottak av tilbud var 2019-05-31. Anskaffelsen ble publisert 2019-04-16.

Leverandører

Følgende leverandører er nevnt i tildelingsbeslutninger eller andre anskaffelsesdokumenter:

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2019-04-16 Kunngjøring av konkurranse
2020-07-28 Kunngjøring om tildeling av kontrakt
Kunngjøring av konkurranse (2019-04-16)
Gjenstand
Anskaffelsens omfang
Tittel: Vaccines
Referansenummer: 19/10795
Kort beskrivelse:
The Norwegian Institute of Public Health shall enter into a contract for the purchase of a combination vaccine for diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (hexavalent vaccine), for the national vaccine programme. The tender contest is carried out on behalf of the Norwegian Institute of Public Health (HOD). Norway has had a hexavalent vaccine programme since 2016. The current contract expires 31.12.2019 and shall be replaced by a new contract subsequent to the tender competition. The procurement shall be implemented as an open tender contest in accordance with the Public Procurement Regulations' Parts 1 and 3. The procurement shall be implemented electronically via the CTM-KGV portal (Eu-Supply) and the tender notice is published in Doffin and TED.
Vis mer
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Vaksiner 📦
Tilleggs-CPV: Vaksiner mot difteri, kikhoste og stivkrampe 📦
Utførelsessted
NUTS-region: Norge 🏙️

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Departement eller annen nasjonal eller føderal myndighet
Navn på tildelende myndighet: Folkehelseinstituttet
Postadresse: Lovisenberggata 8
Postnummer: 0456
Poststed: Oslo
Kontakt
Internettadresse: http://www.fhi.no 🌏
E-post: ole.andreas.fuglesang@fhi.no 📧
Telefon: +47 21076629 📞
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=237670&B=DFO 🌏
URL for deltakelse: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=237670&B=DFO 🌏

Referanse
Datoer
Sendt dato: 2019-04-16 📅
Innleveringsfrist: 2019-05-31 📅
Publiseringsdato: 2019-04-19 📅
Identifikatorer
Kunngjøringsnummer: 2019/S 078-188758
OJ-S-utgave: 78
Tilleggsinformasjon
The Contracting Authority experienced technical problems with attaching the ESPD via the CTM-KGV when publishing the call for tenders. This means that Section III, Part D regarding national rejection justifications are missing in the tender notice. These are conditions that the Norwegian Institute of Public Health cannot control. The tenderers to this tender competition must therefore verify the national rejection justifications that are stated in the tender documentation's Point 3.3 are not applicable, in the KGV-CTM system's section for Requirements and criteria.
Vis mer

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health shall enter into a contract for the purchase of a combination vaccine for diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (hexavalent vaccine), for the national vaccine programme. The tender contest is carried out on behalf of the Norwegian Institute of Public Health (HOD). Norway has had a hexavalent vaccine programme since 2016. The current contract expires 31.12.2019 and shall be replaced by a new contract subsequent to the tender competition.
Vis mer
The procurement shall be implemented as an open tender contest in accordance with the Public Procurement Regulations' Parts 1 and 3. The procurement shall be implemented electronically via the CTM-KGV portal (Eu-Supply) and the tender notice is published in Doffin and TED.
Vis mer
Estimert totalverdi: 240 000 000 NOK 💰
Estimert verdi eksklusive mva: 240 000 000 NOK 💰
Varighet: 24 måneder
Beskrivelse av fornyelser:
The contract period is 2 years, with an option for 1 + 1 year extension. The option for an extension will be taken up automatically for 1 year at a time, unless the Contracting Authority gives notice on the contract in accordance with the Supply Agreement, Point 17. The Contracting Authority aims at signing the contract ASAP after the waiting period.
Vis mer
Beskrivelse av opsjoner:
The contract period is 2 years, with an option for 1 + 1 year extension. The option for an extension will be taken up automatically for 1 year at a time, unless the Contracting Authority gives notice on the contract in accordance with the Supply Agreement, Point 17.
Vis mer
Utførelsessted
Hovedsted eller utførelsessted: Oslo.

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:
Tenderers must be registered in a company register, professional register or a trade register in the state where the tenderer is established.
Documentation requirement:
Norwegian tenderers: company registration certificate.
Foreign tenderers: verification showing that the tenderer is registered in a company register, professional register or a commerce register in the country where the tenderer is established.
Økonomisk og finansiell stilling:
Sufficient economic and financial capacity to be able to fulfil the contract. Creditworthiness with no requirement for guarantees will be sufficient to meet the requirement.
Documentation requirement:
Credit rating based on the most recent financial figures. The rating must be carried out by a credit rating company with a licence to conduct this service.
If a tenderer has valid reasons for not being able to provide the documentation requested by the Contracting Authority, the tenderer can prove his economic and financial position with any other document that the Contracting Authority deems suitable.
Teknisk og faglig kapasitet:
Requirement: the tenderer shall have experience from comparable assignments.
Documentation requirement:
Description of the tenderer's up to 3 most relevant contracts in the course of the last 3 years. The description must include an indication of the assignment product/scope or value, dates and recipients. It is the tenderer's responsibility to document relevance through the description.
Vis mer
Requirement: the tenderer shall have sufficient delivery capacity throughout the contract period.
Documentation: confirmation that the tenderer has the capacity to deliver a sufficient number of doses of the hexavalent vaccine to fulfil the contract.
Requirement: the tenderer shall have the requisite permissions to be able to fulfil the contract.
Documentation: if the tenderer is the manufacturer of the vaccine, permission must be presented from relevant EU/EEA authorities to manufacture pharmaceuticals.
If the tenderer is not the manufacturer of the vaccine, the requisite permissions from relevant EU/EEA authorities to trade in pharmaceuticals must be presented.
If the tenderer imports the vaccine, the import license that includes the offered vaccine must be presented.
Kontraktutførelse
Vilkår for kontraktoppfyllelse:
— the Norwegian Institute of Public Health requires ethical and socially responsible production (Supply Agreement, Points 12, 12.1-12.3),
— the tenderer shall be a member of the Legemiddelansvarsforeningen [Pharmaceutical Liability Association] (Supply Agreement, Point 11.2),
— the Norwegian Institute of Public Health can re-sell, non-distributed, vaccine doses (Supply Agreement, Point 18.1),
— first delivery: 45 000 doses by 31.3.2020 (Supply Agreement, pkt. 4.3),
— the supplier must be able to deliver 200 000 doses per calendar year (Supply agreement Point 3.3),
— the Norwegian Institute of Public Health is obliged to procure a minimum of 150 000 doses per calendar year in the contract period (Supply Agreement Point 3.2).

Prosedyre
Rettslig grunnlag: 32014L0024
Tidspunkt for mottak av tilbud: 13:00
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: engelsk 🗣️
norsk 🗣️
Tilbudets gyldighetsperiode: 2019-08-31 📅
Dato for åpning av tilbud: 2019-05-31 📅
Tidspunkt for åpning av tilbud: 13:00
Sted: The Norwegian Institute of Public Health The tenders will be opened electronically in the CTM-KGV system.
Tildelingskriterier
Kvalitetskriterium (navn): Quality, including effect, safety and user-friendliness
Kvalitetskriterium (vekting): 40
Pris (vekting): 60

Oppdragsgiver
Identitet
Nasjonalt registreringsnummer: 983 744 516
Kontakt
Kontaktpunkt: Ole Andreas Fuglesang
Adresse til kjøperprofilen: https://eu.eu-supply.com/ctm/Company/CompanyInformation/Index/346372 🌏
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=237670&B=DFO 🌏

Referanse
Tilleggsinformasjon
The Contracting Authority experienced technical problems with attaching the ESPD via the CTM-KGV when publishing the call for tenders. This means that Section III, Part D regarding national rejection justifications are missing in the tender notice. These are conditions that the Norwegian Institute of Public Health cannot control.
Vis mer
The tenderers to this tender competition must therefore verify the national rejection justifications that are stated in the tender documentation's Point 3.3 are not applicable, in the KGV-CTM system's section for Requirements and criteria.

Utfyllende informasjon
Klageinstans
Navn: Klagenemnda for offentlige anskaffelser — KOFA
Postadresse: Postbokd 511 sentrum
Poststed: Bergen
Postnummer: 5805
Land: Norge 🇳🇴
Telefon: +47 55193000 📞
E-post: post@knse.no 📧
Internettadresse: https://www.klagenemndssekretariatet.no/klagenemda-for-offentlige-anskaffelser-kofa/ 🌏
Kilde: OJS 2019/S 078-188758 (2019-04-16)
Kunngjøring om tildeling av kontrakt (2020-07-28)
Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health has procured a combination vaccine for diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (Hexavalent vaccine), for the national vaccination programme. This is an announcement of the contest result made in retrospect. The procurement was implemented as an open tender contest in accordance with the Law and Public Procurement Regulations Part 1 and 3. The procurement was carried out electronically via the CTM-KGV portal (EU-Supply) and announced on Doffin and TED.
Vis mer
Totalverdi for anskaffelsen: 1 NOK 💰
Metadata for kunngjøring
Dokumenttype: Kunngjøring om tildeling av kontrakt

Prosedyre
Tilbudstype: Ikke aktuelt

Referanse
Datoer
Sendt dato: 2020-07-28 📅
Publiseringsdato: 2020-07-29 📅
Identifikatorer
Kunngjøringsnummer: 2020/S 145-358116
Refererer til kunngjøring: 2019/S 078-188758
OJ-S-utgave: 145
Tilleggsinformasjon
The contract sum is not stated in the minutes or announcement of contract signing. Justification: Price per dose is the only price element in the contest. If the contract amount were stated, it would be possible to calculate the price per dose of the selected tender using information in the tender documentation. The contracting authority considers the price per dose (unit price) information that it is of competitive importance to keep confidential for the tendering party, which in this case is GSK. Under the provisions of: The Freedom of Information Act §13 and the Administration Act §13 first paragraph point 2. However, the contracting authority states that the actual contract sum is lower than the estimated range for the procurement value stated in the tender documentation.
Vis mer

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health has procured a combination vaccine for diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (Hexavalent vaccine), for the national vaccination programme. This is an announcement of the contest result made in retrospect.
Vis mer
The procurement was implemented as an open tender contest in accordance with the…
… Law and Public Procurement Regulations Part 1 and 3. The procurement was carried out electronically via the CTM-KGV portal (EU-Supply) and announced on Doffin and TED.
… law and public procurement regulations part 1 and 3. The procurement shall be implemented electronically via the CTM-KGV portal (EU-Supply) and the tender notice is published in Doffin and TED.
Beskrivelse av opsjoner:
The contract has a two year duration with an option to extend for an additional 1 year + 1 year. The option for an extension will be triggered automatically for 1 year at a time, unless the contracting authority cancels the contract in accordance with the supply agreement, point 17.
Vis mer

Prosedyre
Tildelingskriterier
Kvalitetskriterium (navn): Quality, including effect, safety and user-friendliness.

Tildeling av kontrakt
Dato for kontraktinngåelse: 2019-07-30 📅
Navn: Glaxosmithkline AS
Nasjonalt registreringsnummer: 930606308
Postadresse: Drammensveien 288
Poststed: Oslo
Postnummer: OSLO 0283
Land: Norge 🇳🇴
Telefon: +47 98834058 📞
E-post: kristin.x.kittelsen@gsk.com 📧
Totalverdi for anskaffelsen: 1 NOK 💰
Informasjon om tilbud
Antall mottatte tilbud: 2

Referanse
Tilleggsinformasjon
The contract sum is not stated in the minutes or announcement of contract signing.
Justification:
Price per dose is the only price element in the contest. If the contract amount were stated, it would be possible to calculate the price per dose of the selected tender using information in the tender documentation. The contracting authority considers the price per dose (unit price) information that it is of competitive importance to keep confidential for the tendering party, which in this case is GSK. Under the provisions of: The Freedom of Information Act §13 and the Administration Act §13 first paragraph point 2. However, the contracting authority states that the actual contract sum is lower than the estimated range for the procurement value stated in the tender documentation.
Vis mer

Utfyllende informasjon
Klageinstans
Navn: Oslo Tingrett
Postadresse: Postboks 2106 Vika
Poststed: oslo
Postnummer: 0125
Telefon: +47 22035200 📞
E-post: oslo.tingrett@domstol.no 📧
Internettadresse: https://www.domstol.no/Enkelt-domstol/oslotingrett/ 🌏
Organ ansvarlig for meklingsprosedyrer
Navn: Klagenemnda for offentlige anskaffelser – KOFA
Postadresse: Postbokd 511 Sentrum
Poststed: Bergen
Postnummer: 5805
Land: Norge 🇳🇴
Telefon: +47 55193000 📞
E-post: post@knse.no 📧
Internettadresse: www.kofa.no 🌏
Kilde: OJS 2020/S 145-358116 (2020-07-28)
Nye anskaffelser i relaterte kategorier 🆕
Relaterte søk 🔍
Produkter/tjenester:
Medisinsk utstyr, legemidler og utstyr... Farmasøytiske produkter Antiinfektive midler for systemisk bruk,... Antiinfektive midler for systemisk bruk Vaksiner Vaksiner mot difteri, kikhoste og stivkrampe Vaksiner mot difteri og stivkrampe Poliovaksiner Vaksiner mot hepatitt B